Related Experiment Videos
[Pharma-clinics medication of the month. Rabeprazole (Pariet)]
1Service de Gastroentérologie, CHU de Liège.
Revue Medicale De Liege
|March 20, 2002
Abstract:
Proton pomp inhibitors (PPI) have revolutionized the treatment of gastro-oesophageal reflux disease and gastro-duodenal ulcers. Rabeprazole (Pariet) is the last PPI arrived on the Belgian market. Controlled studies have shown an efficacy similar to emeprazole in the treatment of oeso-gastro-duodenal acid diseases. Rabeprazole has a favourable profile with rapid action and good safety.